Portfolio company
ForSight VISION6 Inc
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops accommodating intraocular lenses for ophthalmic surgeons to restore precise vision across all distances for patients following cataract surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Adaptilens
Adaptilens develops flexible intraocular lenses that mimic the natural focus of the eye for patients undergoing cataract surgery to eliminate dependence on glasses.
VisusNano
This company develops drug-eluting intraocular lens implants for patients undergoing cataract surgery to eliminate the need for post-operative eye drops.
SpyGlass Pharma, Inc
The company develops an intraocular lens drug delivery system for patients with glaucoma to provide long-term medication during cataract surgery.
Aquesys
This company develops and manufactures ocular implants for glaucoma patients to reduce intraocular pressure through minimally invasive surgical procedures.
2eyesVision
This company develops visual simulators that allow patients to experience multifocal corrections before undergoing cataract surgery or receiving contact lens fittings.
Orasis Pharmaceuticals
This company develops prescription eye drops for adults with age-related blurry near vision.
IXI
This company develops autofocus glasses using real-time eye-tracking and dynamic lens technology for consumers with vision correction needs.
Pixium Vision
This company develops bionic vision restoration systems and retinal implants for patients who have lost their sight due to degenerative eye diseases.
